Mounjaro® mimics two gut hormones called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). When you eat, these hormones slow digestion and help you feel full. Mounjaro also:
Mounjaro is a dual receptor agonist drug approved by the U.S. Food and Drug Administration (FDA) to treat Type 2 diabetes. Clinicians prescribe it off-label for weight loss because clinical evidence shows it also helps people lose weight.
Mounjaro is a brand name for tirzepatide and it is manufactured by Eli Lilly.
Mounjaro is available as an injection. Currently, there’s no generic version of Mounjaro that’s been approved by the FDA.
Expected weight loss depends on the dosage. In a study funded by its manufacturer, Eli Lilly, participants taking 15 mg of tirzepatide lost an average of 48 pounds over 72 weeks, while those taking 5 mg of tirzepatide lost 34 pounds.
Mounjaro also improves heart health by improving heart health metrics like blood pressure, blood sugar levels, and cholesterol, and helping people lose excess weight. Multiple clinical trials funded by Eli Lilly show tirzepatide can reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with Type 2 diabetes and those with overweight or obesity.
It’s significant to note that some patients have reported reduced cravings and “food noise” and increased quality of life while using Mounjaro.
When you eat, the food stimulates your gut to release GLP-1 and GIP. When blood sugar levels are high after a meal, GLP-1 helps the pancreas release the right amount of insulin and slows how quickly the food moves through the digestive system. It also decreases glucagon, a hormone that controls the amount of glucose (blood sugar) the liver makes. GIP stimulates insulin release to help regulate low blood sugar levels after eating.
In some people, the gut doesn’t make enough of these hormones on its own, or the brain isn’t sensitive to them.
Mounjaro is a combination of synthetic GIP and GLP-1, which acts as a dual receptor agonist (RA). A drug that works as an agonist activates the same cell receptors as the body’s natural hormones. So, Mounjaro works in the gut like the body’s natural GLP-1 and GIP. Because Mounjaro slows digestion, it helps curb hunger and signal fullness to the brain. It also prompts insulin release, maintaining blood sugar levels after a meal. As a result, some people with obesity and overweight have lost weight while taking it.
Because Mounjaro supports a process the body isn’t doing well on its own, it may require long-term use.
It’s important to note that Mounjaro doesn’t work for everyone. There are many biological reasons why people struggle to lose weight. Found’s clinicians, trained in obesity medicine, can help patients identify the root cause of their weight gain and personalize a prescription to target it. All prescriptions are up to a medical provider’s discretion.
© 2025 BestMan Med. All rights reserved
BestMan Med, is a marketplace platform, collaborates with independent healthcare professionals to deliver top-notch services through our BestManMed.com Patient Management System. We do not directly offer medical or pharmacy services, and payment doesn’t ensure the prescription’s writing or dispensing. Independent providers handle medical services. Information on this site is for reference only and doesn’t replace professional medical advice. For health-related inquiries, consult your doctor. Our platform is an advertisement for services, not specific medications.
*Disclaimer: The FDA-approved brand name drugs, such as Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk® company. Mounjaro® and Zepbound® is exclusively available from Eli Lilly and Company®. OrderlyMeds® does not claim any affiliation with, or endorsement from, the above mentioned products or entities.
